Market Closed -
Canadian Securities Exchange
01:06:21 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
0.015
CAD
|
0.00%
|
|
-25.00%
|
+50.00%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
70.34
|
85.05
|
88.76
|
41.41
|
7.765
|
1.076
|
Enterprise Value (EV)
1 |
66.88
|
74.3
|
122.3
|
75.12
|
28.6
|
18.73
|
P/E ratio
|
-28.6
x
|
-12.2
x
|
-0.61
x
|
-0.35
x
|
-1.35
x
|
-0.01
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
22,829,298,354
x
|
27,760,439
x
|
8,365,937
x
|
1,598,106
x
|
EV / Revenue
|
-
|
-
|
31,463,131,944
x
|
50,356,796
x
|
30,815,216
x
|
27,812,179
x
|
EV / EBITDA
|
-30.9
x
|
-13.7
x
|
-2.17
x
|
-4.06
x
|
-5.87
x
|
-9.64
x
|
EV / FCF
|
-177
x
|
-67.1
x
|
18.1
x
|
7.76
x
|
-0.96
x
|
-7.55
x
|
FCF Yield
|
-0.57%
|
-1.49%
|
5.51%
|
12.9%
|
-104%
|
-13.3%
|
Price to Book
|
11.2
x
|
2.91
x
|
1.33
x
|
8.72
x
|
0.4
x
|
-0.06
x
|
Nbr of stocks (in thousands)
|
69.5
|
98.6
|
249
|
402
|
536
|
4,305
|
Reference price
2 |
1,012
|
862.5
|
356.2
|
103.1
|
14.50
|
0.2500
|
Announcement Date
|
4/30/18
|
5/2/19
|
6/15/20
|
5/3/21
|
5/2/22
|
5/1/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
|
-
|
-
|
0.003888
|
1.492
|
0.9282
|
0.6734
|
EBITDA
1 |
-2.164
|
-5.424
|
-56.49
|
-18.5
|
-4.876
|
-1.943
|
EBIT
1 |
-2.168
|
-5.437
|
-56.53
|
-19.19
|
-5.036
|
-2.049
|
Operating Margin
|
-
|
-
|
-1,453,920.91%
|
-1,286.67%
|
-542.54%
|
-304.26%
|
Earnings before Tax (EBT)
1 |
-2.12
|
-5.82
|
-101.7
|
-103.2
|
-2.414
|
-20.03
|
Net income
1 |
-2.04
|
-5.741
|
-101
|
-102.9
|
-5.096
|
-41.93
|
Net margin
|
-
|
-
|
-2,597,249.67%
|
-6,895.34%
|
-548.98%
|
-6,227.17%
|
EPS
2 |
-35.46
|
-70.73
|
-581.5
|
-294.8
|
-10.71
|
-19.72
|
Free Cash Flow
1 |
-0.3781
|
-1.107
|
6.743
|
9.674
|
-29.87
|
-2.482
|
FCF margin
|
-
|
-
|
173,434.34%
|
648.53%
|
-3,217.62%
|
-368.61%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/30/18
|
5/2/19
|
6/15/20
|
5/3/21
|
5/2/22
|
5/1/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
-
|
33.6
|
33.7
|
20.8
|
17.7
|
Net Cash position
1 |
3.46
|
10.7
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-0.5942
x
|
-1.822
x
|
-4.274
x
|
-9.087
x
|
Free Cash Flow
1 |
-0.38
|
-1.11
|
6.74
|
9.67
|
-29.9
|
-2.48
|
ROE (net income / shareholders' equity)
|
-47.1%
|
-31.3%
|
-212%
|
-296%
|
-21.2%
|
-36,362%
|
ROA (Net income/ Total Assets)
|
-25.1%
|
-17.4%
|
-51.3%
|
-14.2%
|
-5.83%
|
-5.41%
|
Assets
1 |
8.13
|
33.01
|
196.7
|
726
|
87.39
|
774.6
|
Book Value Per Share
2 |
90.30
|
296.0
|
268.0
|
11.80
|
35.90
|
-4.360
|
Cash Flow per Share
2 |
51.50
|
107.0
|
16.40
|
0.6800
|
5.780
|
0.0700
|
Capex
1 |
0.18
|
0.5
|
4.23
|
5.62
|
0.01
|
-
|
Capex / Sales
|
-
|
-
|
108,700.46%
|
376.54%
|
0.9%
|
-
|
Announcement Date
|
4/30/18
|
5/2/19
|
6/15/20
|
5/3/21
|
5/2/22
|
5/1/23
|
|
1st Jan change
|
Capi.
|
---|
| +50.00% | 210K | | +31.96% | 272M | | +33.74% | 261M | | +49.42% | 194M | | +44.98% | 131M | | -42.17% | 119M | | -28.57% | 121M | | +115.91% | 119M | | 0.00% | 86.82M | | +150.00% | 75.33M |
Medical Farming
|